MT 4 McNEIL (Pancreaze 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease)

Generic Name: pancrelipase

Pill with imprint MT 4 McNEIL is Yellow / Clear, Capsule-shape and has been identified as Pancreaze 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease. It is supplied by Ortho-McNeil-Janssen Pharmaceuticals, Inc..

Pancreaze is used in the treatment of chronic pancreatitis; pancreatic exocrine dysfunction; cystic fibrosis and belongs to the drug class digestive enzymes. Risk cannot be ruled out during pregnancy. Pancreaze 17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease is not a controlled substance under the Controlled Substances Act (CSA).

Images for MT 4 McNEIL

Pancreaze

Generic Name

pancrelipase

Imprint

MT 4 McNEIL

Strength

17,500 USP units amylase; 4,200 USP units lipase; 10,000 USP units protease

Color

Yellow / Clear

Size

15.00 mm

Shape

Capsule-shape

Availability

Prescription only

Drug Class

Digestive enzymes

Pregnancy Category

C - Risk cannot be ruled out

CSA Schedule

Not a controlled drug

Labeler / Supplier

Ortho-McNeil-Janssen Pharmaceuticals, Inc.

National Drug Code (NDC)

50458-0341

Inactive Ingredients

microcrystalline cellulose, silicon dioxide, magnesium stearate, methacrylic acid - ethyl acrylate copolymer (1:1) type a, triethyl citrate, magnesium silicate, dimethicone, gelatin, titanium dioxide, sodium lauryl sulfate, sorbitan monolaurate, ferric oxide yellow

Note: Inactive ingredients may vary.

More Info Imprint Search Print

Get help with Imprint Code FAQs.

Related Images for "MT 4 McNEIL"

Pancrease MT 4

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer